Custom Search

Rituximab News

International Approvals: NuvaRing, MabThera, Gemzar

Australia's Therapeutic Goods Administration has approved a once-monthly etonogestrel/ethinyl estradiol vaginal ring for contraceptive use in women; the European Commission has approved a new indication for rituximab injection,...

Rituximab is granted EU approval as maintenance therapy for NHL

The European Commission has approved the use of the drug rituximab as a maintenance therapy for people with follicular non-Hodgkin's lymphoma (NHL) that has relapsed or not responded to previous treatment.

EU Approves Roche Top-Selling Cancer Drug For Arthritis

Zurich, Switzerland (AHN) - Swiss drug maker, Roche, said on Tuesday that the European Commission had approved its drug MabThera, a cancer-drug, to treat lymphoma patients with arthritis.

Roche's MabThera gets new EU lymphoma OK

The European Commission has approved Roche's MabThera as maintenance therapy for patients with relapsed or refractory follicular non-Hodgkin's lymphoma, a common form of lymphoma.

Roche's Mabthera receives EU approval for rheumatoid arthritis, NHL

The drug has been indicated as a combination treatment for adults with severe active rheumatoid arthritis, who have had an inadequate response or are intolerant to current treatment options, the Swiss pharma group said.

Displaying results 16 to 20 out of 24

< Previous






Next >

Use of this site is subject to the following terms of use